Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A
about
Beta-blockers for preventing stroke recurrenceBeta-blockers for hypertensionTreatment of hypertension in peripheral arterial diseaseBeta-blockers for hypertensionBeta-blockers for preventing stroke recurrenceAngiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney diseaseCalcium channel blockers versus other classes of drugs for hypertensionWalking for hypertensionBlood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementiaBeta blockers for preventing stroke recurrenceTreatment of hypertension in peripheral arterial diseaseAngiotensin converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1-3) non-diabetic chronic kidney diseaseRe-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysisCarvedilol in hypertension treatmentManidipine-delapril combination in the management of hypertensionComparative Effectiveness of Blood Pressure-lowering Drugs in Patients who have Already Suffered From Stroke: Traditional and Bayesian Network Meta-analysis of Randomized TrialsTimeline of History of Hypertension TreatmentUnderstanding and treating hypertension in diabetic populationsA Review of Nebivolol Pharmacology and Clinical EvidenceLong-term safety and efficacy of telmisartan/amlodipine single pill combination in the treatment of hypertensionBeta-Blockers in the Management of Hypertension and/or Chronic Kidney Diseaseβ-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literatureBlood pressure control and primary prevention of stroke: summary of the recent clinical trial data and meta-analysesDoes it matter where we measure blood pressure?Calcium channel blockersPre-hypertension: how low to go and do drugs have a role?Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patientsThe perils of surrogate endpointsIs blood pressure reduction a valid surrogate endpoint for stroke prevention? An analysis incorporating a systematic review of randomised controlled trials, a by-trial weighted errors-in-variables regression, the surrogate threshold effect (STE) andNovel Uses of Office-Based Measures of Arterial ComplianceCombination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidenceEvaluating and treating cardiometabolic risk factors: a case discussionStroke prevention in diabetes and obesityCardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysisThe 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - TherapyMultivariate risk assessment and risk score cards in hypertensionPharmacological prevention of atherothrombotic events in patients with peripheral arterial diseaseClinical updates on carvedilol: a first choice beta-blocker in the treatment of cardiovascular diseasesSecular Trends in Prescription Patterns of Single-Pill Combinations of an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Plus a Thiazide Diuretic for Hypertensive Patients in TaiwanThe effects of calcium channel blockers in the prevention of stroke in adults with hypertension: a meta-analysis of data from 273,543 participants in 31 randomized controlled trials
P2860
Q24193102-010FA4B9-923B-4259-9A11-347E422D65F6Q24201511-84E3007F-9628-4E17-923B-FCAFA0114226Q24201969-D605EA93-CA44-4B2F-8C15-37899194A665Q24202812-E98A9512-AF74-46EC-BF61-8CE238BD47A4Q24202904-2EE943EE-26B0-4F05-A691-41D3A7801029Q24235834-0483D401-6C7A-4FC4-A447-1B4B6C5ACBD7Q24236584-4E8B1B7F-100F-468D-9BFE-BAB516791855Q24236765-2AE6C4D5-EBB9-43EC-930B-23FAE755DDFFQ24240206-A75DF150-E53D-4AE2-BBD2-92ECEE90B509Q24240367-7B2B82D6-B749-4E10-BF09-23F455B1FF81Q24240538-EADC987F-FED9-470E-87F3-133164A2DB61Q24241947-7918A6E5-ACDA-441C-AE35-B6F048A4B6FBQ24545775-A383102F-D700-4172-91C3-611BD8A7E7C6Q24642654-F94FAC26-A83F-427A-B8A6-F90684EB5749Q24654799-5F69E3E4-5D9B-4824-9BF3-EF083DC68991Q26747669-54363DF7-9A64-425D-9932-E1F8B3DE406BQ26768219-6587E93C-AC02-4996-8E1A-D41AAE03513EQ26778662-AD0796BA-306E-44C4-9580-79BF74F85CFCQ26801287-FB95AD79-A367-440C-9351-130A0836D02CQ26824261-0470A1CC-F5A5-4558-A3DB-F7967582BE91Q26825409-AEBA257E-0CFA-4C78-BD42-600603DA5140Q26861630-053EAC3B-C20E-437E-92D3-888FC9785959Q26996563-7DAEB144-6A30-4E6D-9C39-85415EA7DF72Q26999237-A6AF6D9A-7270-459F-B204-6C983EB468C2Q27003120-0F1E4E39-59AB-4667-922C-5D14B2FD1CBFQ27007552-D96429B4-22D2-4C0A-9415-D2116CE99D4DQ27023161-BC0B544E-6529-455C-8172-7AAADD7588D9Q27025740-FA3BE64E-8C9C-4883-8BD9-EFCD57B3BA0BQ27025943-144276C1-9872-49DB-8E63-2A880605C64BQ28073696-453D70DE-073E-4CE7-B186-04072C1138E5Q28074644-80C392A6-13D3-485C-B554-5E23936A971EQ28196750-FFDDB070-F8E7-4CD0-93E9-E225DACBD29BQ28200179-A530E22F-99E1-440F-8F3B-602066C7DFADQ28200196-E77D7F51-940B-47A9-B89A-76E9425EED2AQ28218811-9DA775A8-3CC6-4184-8A14-C8870E28FE05Q28219606-12B46D10-D195-41BD-9731-04C7F21BA7CEQ28220999-A98718A6-2DC3-4523-A4B3-21A7A95B115FQ28270431-DD86EC31-DA8B-4933-8529-9967D781C7BDQ28468718-1B50B7E8-B6B7-4DE4-ABD6-B5D69E21EA51Q28487721-51026AE0-5DFD-4AC1-BC9A-9130C0A89E4B
P2860
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Prevention of cardiovascular e ...... Blood Pressure Lowering Arm (A
@ast
Prevention of cardiovascular e ...... Blood Pressure Lowering Arm (A
@en
type
label
Prevention of cardiovascular e ...... Blood Pressure Lowering Arm (A
@ast
Prevention of cardiovascular e ...... Blood Pressure Lowering Arm (A
@en
prefLabel
Prevention of cardiovascular e ...... Blood Pressure Lowering Arm (A
@ast
Prevention of cardiovascular e ...... Blood Pressure Lowering Arm (A
@en
P2093
P50
P1433
P1476
Prevention of cardiovascular e ...... Blood Pressure Lowering Arm (A
@en
P2093
ASCOT Investigators
Arni Kristinsson
D Gareth Beevers
Eoin O'Brien
Gordon T McInnes
Hans Wedel
Jan Ostergren
Jesper Mehlsen
Markku Nieminen
Neil R Poulter
P304
P356
10.1016/S0140-6736(05)67185-1
P407
P577
2005-09-01T00:00:00Z